|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| A61K 39/3955 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/22 | (2013.01) | ||
| A61K 35/768 | (2015.01) | ||
| C12N2750/14332 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61K 35/768 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3256162 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16711533.6 |
| Date of filing the European patent application | 2016-02-10 | |
| (97) | Date of publication of the European application | 2017-12-20 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/025008 |
| Date | 2016-02-10 |
| (87) | Number | WO 2016/128146 |
| Date | 2016-08-18 |
| (30) | Number | Date | Country code |
| 15154629 | 2015-02-11 | EP |
| (72) |
GELETNEKY, Karsten , DE
ROMMELAERE, Jean , DE
WICK, Wolfgang , DE
WICK, Antje , DE
DAHM, Michael , DE
|
| (73) |
Deutsches Krebsforschungszentrum ,
Im Neuenheimer Feld 280, 69120 Heidelberg,
DE
Ruprecht-Karls-Universität , Grabengasse 1, 69117 Heidelberg, DE |
| (54) | CANCER THERAPY WITH A PARVOVIRUS COMBINED WITH BEVACIZUMAB |
| CANCER THERAPY WITH A PARVOVIRUS COMBINED WITH BEVACIZUMAB |